Effective therapeutic dosage of antipsychotic medications in patients with psychotic symptoms: Is there a racial difference?

BMC Research Notes

Volumn 1, Issue , 2008, Pages

  Bakare, Muideen O ^a  

^a Federal Neuro psychiatric Hospital Enugu   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 75949102491     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-1-25     Document Type: Article

References (22)

1. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. L Bertilsson, Clin Pharmacokinet 1995 29 3 192 209 8521680
2. Genetic polymorphism of drug metabolizing enzymes in African populations: implications for the use of neuroleptics and antidepressants. CM Masimirembwa JA Hasler, Brain Res Bull 1997 44 5 561 571 10.1016/S0361-9230(97)00307-9 9365799
3. Pharmacogenetics and psychopharmacotherapy. N Poolsup A Li Wan Po TL Knight, J Clin Pharm Ther 2000 25 3 197 220 10.1046/j.1365-2710.2000.00281.x 10886465
4. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. J Kirchheiner K Nickchen M Bauer ML Wong J Licinio I Roots J Brockmoller, Mol Psychiatry 2004 9 5 442 473 10.1038/sj.mp.4001494 15037866
5. Haloperidol and prolactin concentrations in Asians and Caucasians. KM Lin RE Poland JK Lau RT Rubin, J Clin Psychopharmacol 1988 8 3 195 201 10.1097/00004714-198806000-00008 3379143
6. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. KM Lin RE Poland I Nuccio K Matsuda N Hathuc TP Su P Fu, Am J Psychiatry 1989 146 10 1307 1311 2782476
7. Subjective experience and D2 receptor occupancy in patients with recent onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized double-blind study. L de Haan M van Bruggen J Lavalaye J Booij PM Dingemans D Linszen, Am J Psychiatry 2003 160 2 303 309 10.1176/appi.ajp.160.2. 303 12562577
8. Ethnicity and psychopharmacology. KM Lin RE Poland IM Lesser, Cult Med Psychiatry 1986 10 2 151 165 10.1007/BF00156581 2872996
9. Ethnic psychopharmacology: the Hispanic and Native American perspective. R Mendoza MW Smith RE Poland KM Lin TL Strickland, Psychopharmacol Bull 1991 27 4 449 461 1813894
10. Culture and psychopharmacology. KM Lin MW Smith V Ortiz, Psychiatr Clin North Am 2001 24 3 523 538 10.1016/S0193-953X(05)70245-8 11593861
11. Prescribing for inpatients with schizophrenia: an international multi-center comparative study. I Bitter JC Chou GS Ungvari WK Tang Z Xiang A Iwanami P Gaszner, Pharmacopsychiatry 2003 36 4 143 149 10.1055/s-2003-41199 12905100
12. Psychotropic drug prescription in Nigeria. OO Famuyiwa, Acta Psychiatr Scand 1983 68 2 73 81 10.1111/j.1600-0447.1983.tb06984.x 6137939
13. Prescribing habits for psychiatric in-patient admissions in a Nigerian psychiatric hospital. TA Adamson, Afr J Med Med Sci 1995 24 3 261 267 8798962
14. British National Formulary. British Medical Association and Royal Pharmaceutical Society, BMA and Royal Pharmaceutical Society 2005 49
15. th Edition). D Taylor C Paton R Kerwin, Taylor and Francis 2005
16. Differential prescription of maintenance antipsychotics to African-American and white patients with new-onset bipolar disorder. DE Fleck WL Hendricks MP Del Bello SM Strakowski, J Clin Psychiatry 2002 63 8 658 664 12197445
17. Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder. NC Patel MP Del Bello PE Keck Jr SM Strakowski, J Child Adolesc Psychopharmacol 2005 15 6 938 946 10.1089/cap.2005.15.938 16379514
18. Patients with schizophrenia at risk for excessive antipsychotic dosing. JT Walkup DD Mc Alpine M Olfson LE Labay C Boyer S Hansell, J Clin Psychiatry 2000 61 5 344 348 10847308
19. Excessive antipsychotic dosing in 2 U.S. State hospitals. FJ Diaz J De Leon, J Clin Psychiatry 2002 63 11 998 1003 12444813
20. High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. K Sim A Su JY Leong K Yip MY Chong S Fujii S Yang GS Ungvari T Si EK Chung HY Tsang N Shinfuku EH Kua CH Tan, Pharmacopsychiatry 2004 37 4 175 9 10.1055/s-2004-827174 15467975
21. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study. C Barbui B Biancosino E Esposito L Marmai S Dona L Grassi, Int Clin Psychopharnacol 2007 22 4 221 5 10.1097/YIC.0b013e3281084ea8 (Pubitemid 46801945)
22. Sex, ethnicity and antipsychotic medication use in patients with psychosis. LM Arnold SM Strakowski ML Schwiers J Amicone DE Fleck KB Corey JE Farrow, Schizophr Res 66 2-3 169 75 2004 Feb 1; 15061250